Sort   by:  
 Page size 
Polymyxin B (PB) is introduced into the clinic as the last-line therapy against carbapenem-resistant Klebsiella pneumoniae (CRKP). Unfortunately, increased resistance to PB in Klebsiella pneumoniae (K. pneumoniae) has threatened global health. Resistance of K. pneumoniae ...
2022-03-04 | MTBLS4132 | MetaboLights
Comparison of transcriptome of E. coli K-12 wild type strain with transcriptome of E. coli K-12-R, highly tolerant to PPEF an antibacterial agent.
Sort   by:  
 Page size